Nebraska Methodist Estabrook Cancer Center — Omaha, Nebraska

Nebraska Methodist Estabrook Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Methodist Estabrook Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Non-Small-Cell Lung.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Estabrook Cancer Center?

Nebraska Methodist Estabrook Cancer Center has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Estabrook Cancer Center conducted?

Nebraska Methodist Estabrook Cancer Center has 1 clinical trials on record. Their work covers Non-Small-Cell Lung.

Is Nebraska Methodist Estabrook Cancer Center accredited by Crixeo Health?

Nebraska Methodist Estabrook Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Estabrook Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.